Skip to main content
logo
Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
69.85
+0.16 (0.23%)
At close: Oct 31, 2025, 4:00 PM EDT
69.83
-0.02 (-0.03%)
After-hours: Oct 31, 2025, 7:29 PM EDT

Avidity Biosciences Revenue

Avidity Biosciences had revenue of $3.85M in the quarter ending June 30, 2025, with 88.12% growth. This brings the company's revenue in the last twelve months to $10.73M, up 1.23% year-over-year. In the year 2024, Avidity Biosciences had annual revenue of $10.90M with 13.99% growth.

Revenue (ttm)
$10.73M
Revenue Growth
+1.23%
P/S Ratio
935.24
Revenue / Employee
$27,440
Employees
391
Market Cap
10.03B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.90M1.34M13.99%
Dec 31, 20239.56M336.00K3.64%
Dec 31, 20229.22M-102.00K-1.09%
Dec 31, 20219.33M2.54M37.41%
Dec 31, 20206.79M4.47M192.67%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

RNA News

More News